id	sid	tid	token	lemma	pos
ajlm-2582	1	1	acknowledgements	acknowledgement	NOUN
ajlm-2582	1	2	references	reference	NOUN
ajlm-2582	1	3	about	about	ADP
ajlm-2582	1	4	the	the	DET
ajlm-2582	1	5	author(s	author(s	NOUN
ajlm-2582	1	6	)	)	PUNCT
ajlm-2582	1	7	zohreh	zohreh	PROPN
ajlm-2582	1	8	jadali	jadali	PROPN
ajlm-2582	1	9	department	department	PROPN
ajlm-2582	1	10	of	of	ADP
ajlm-2582	1	11	immunology	immunology	NOUN
ajlm-2582	1	12	,	,	PUNCT
ajlm-2582	1	13	school	school	NOUN
ajlm-2582	1	14	of	of	ADP
ajlm-2582	1	15	public	public	ADJ
ajlm-2582	1	16	health	health	NOUN
ajlm-2582	1	17	,	,	PUNCT
ajlm-2582	1	18	tehran	tehran	PROPN
ajlm-2582	1	19	university	university	PROPN
ajlm-2582	1	20	of	of	ADP
ajlm-2582	1	21	medical	medical	ADJ
ajlm-2582	1	22	sciences	sciences	PROPN
ajlm-2582	1	23	,	,	PUNCT
ajlm-2582	1	24	tehran	tehran	PROPN
ajlm-2582	1	25	,	,	PUNCT
ajlm-2582	1	26	iran	iran	PROPN
ajlm-2582	1	27	citation	citation	PROPN
ajlm-2582	1	28	jadali	jadali	PROPN
ajlm-2582	1	29	z.	z.	PROPN
ajlm-2582	1	30	pathobiology	pathobiology	PROPN
ajlm-2582	1	31	of	of	ADP
ajlm-2582	1	32	hiv	hiv	PROPN
ajlm-2582	1	33	-	-	PUNCT
ajlm-2582	1	34	related	relate	VERB
ajlm-2582	1	35	metabolic	metabolic	NOUN
ajlm-2582	1	36	and	and	CCONJ
ajlm-2582	1	37	cardiovascular	cardiovascular	ADJ
ajlm-2582	1	38	comorbidities	comorbiditie	NOUN
ajlm-2582	1	39	:	:	PUNCT
ajlm-2582	1	40	towards	towards	ADP
ajlm-2582	1	41	a	a	DET
ajlm-2582	1	42	unifying	unifying	ADJ
ajlm-2582	1	43	mechanism	mechanism	NOUN
ajlm-2582	1	44	.	.	PUNCT
ajlm-2582	2	1	afr	afr	PROPN
ajlm-2582	2	2	j	j	PROPN
ajlm-2582	2	3	lab	lab	PROPN
ajlm-2582	2	4	med	me	VERB
ajlm-2582	2	5	.	.	PUNCT
ajlm-2582	3	1	2024;13(1	2024;13(1	NUM
ajlm-2582	3	2	)	)	PUNCT
ajlm-2582	3	3	,	,	PUNCT
ajlm-2582	3	4	a2582	a2582	PROPN
ajlm-2582	3	5	.	.	PROPN
ajlm-2582	3	6	https://doi.org/10.4102/ajlm.v13i1.2582	https://doi.org/10.4102/ajlm.v13i1.2582	AUX
ajlm-2582	3	7	scientific	scientific	ADJ
ajlm-2582	3	8	letter	letter	NOUN
ajlm-2582	3	9	pathobiology	pathobiology	NOUN
ajlm-2582	3	10	of	of	ADP
ajlm-2582	3	11	hiv	hiv	PROPN
ajlm-2582	3	12	-	-	PUNCT
ajlm-2582	3	13	related	relate	VERB
ajlm-2582	3	14	metabolic	metabolic	NOUN
ajlm-2582	3	15	and	and	CCONJ
ajlm-2582	3	16	cardiovascular	cardiovascular	ADJ
ajlm-2582	3	17	comorbidities	comorbiditie	NOUN
ajlm-2582	3	18	:	:	PUNCT
ajlm-2582	3	19	towards	towards	ADP
ajlm-2582	3	20	a	a	DET
ajlm-2582	3	21	unifying	unifying	ADJ
ajlm-2582	3	22	mechanism	mechanism	NOUN
ajlm-2582	3	23	zohreh	zohreh	NOUN
ajlm-2582	3	24	jadali	jadali	PROPN
ajlm-2582	3	25	received	receive	VERB
ajlm-2582	3	26	:	:	PUNCT
ajlm-2582	3	27	24	24	NUM
ajlm-2582	3	28	july	july	PROPN
ajlm-2582	3	29	2024	2024	NUM
ajlm-2582	3	30	;	;	PUNCT
ajlm-2582	3	31	accepted	accept	VERB
ajlm-2582	3	32	:	:	PUNCT
ajlm-2582	3	33	04	04	NUM
ajlm-2582	3	34	sept	sept	PROPN
ajlm-2582	3	35	.	.	PROPN
ajlm-2582	3	36	2024	2024	NUM
ajlm-2582	3	37	;	;	PUNCT
ajlm-2582	3	38	published	publish	VERB
ajlm-2582	3	39	:	:	PUNCT
ajlm-2582	3	40	25	25	NUM
ajlm-2582	3	41	oct	oct	PROPN
ajlm-2582	3	42	.	.	PROPN
ajlm-2582	3	43	2024	2024	NUM
ajlm-2582	3	44	copyright	copyright	NOUN
ajlm-2582	3	45	:	:	PUNCT
ajlm-2582	3	46	©	©	PROPN
ajlm-2582	3	47	2024	2024	NUM
ajlm-2582	3	48	.	.	PUNCT
ajlm-2582	4	1	the	the	DET
ajlm-2582	4	2	author(s	author(s	PROPN
ajlm-2582	4	3	)	)	PUNCT
ajlm-2582	4	4	.	.	PUNCT
ajlm-2582	5	1	licensee	licensee	NOUN
ajlm-2582	5	2	:	:	PUNCT
ajlm-2582	5	3	aosis	aosis	NOUN
ajlm-2582	5	4	.	.	PUNCT
ajlm-2582	6	1	this	this	PRON
ajlm-2582	6	2	is	be	AUX
ajlm-2582	6	3	an	an	DET
ajlm-2582	6	4	open	open	ADJ
ajlm-2582	6	5	access	access	NOUN
ajlm-2582	6	6	article	article	NOUN
ajlm-2582	6	7	distributed	distribute	VERB
ajlm-2582	6	8	under	under	ADP
ajlm-2582	6	9	the	the	DET
ajlm-2582	6	10	terms	term	NOUN
ajlm-2582	6	11	of	of	ADP
ajlm-2582	6	12	the	the	DET
ajlm-2582	6	13	creative	creative	ADJ
ajlm-2582	6	14	commons	common	NOUN
ajlm-2582	6	15	attribution	attribution	NOUN
ajlm-2582	6	16	license	license	NOUN
ajlm-2582	6	17	,	,	PUNCT
ajlm-2582	6	18	which	which	PRON
ajlm-2582	6	19	permits	permit	VERB
ajlm-2582	6	20	unrestricted	unrestricted	ADJ
ajlm-2582	6	21	use	use	NOUN
ajlm-2582	6	22	,	,	PUNCT
ajlm-2582	6	23	distribution	distribution	NOUN
ajlm-2582	6	24	,	,	PUNCT
ajlm-2582	6	25	and	and	CCONJ
ajlm-2582	6	26	reproduction	reproduction	NOUN
ajlm-2582	6	27	in	in	ADP
ajlm-2582	6	28	any	any	DET
ajlm-2582	6	29	medium	medium	NOUN
ajlm-2582	6	30	,	,	PUNCT
ajlm-2582	6	31	provided	provide	VERB
ajlm-2582	6	32	the	the	DET
ajlm-2582	6	33	original	original	ADJ
ajlm-2582	6	34	work	work	NOUN
ajlm-2582	6	35	is	be	AUX
ajlm-2582	6	36	properly	properly	ADV
ajlm-2582	6	37	cited	cite	VERB
ajlm-2582	6	38	.	.	PUNCT
ajlm-2582	7	1	the	the	DET
ajlm-2582	7	2	recently	recently	ADV
ajlm-2582	7	3	published	publish	VERB
ajlm-2582	7	4	african	african	ADJ
ajlm-2582	7	5	journal	journal	NOUN
ajlm-2582	7	6	of	of	ADP
ajlm-2582	7	7	laboratory	laboratory	NOUN
ajlm-2582	7	8	medicine	medicine	NOUN
ajlm-2582	7	9	article	article	NOUN
ajlm-2582	7	10	by	by	ADP
ajlm-2582	7	11	okunorobo	okunorobo	PROPN
ajlm-2582	7	12	et	et	PROPN
ajlm-2582	7	13	al	al	PROPN
ajlm-2582	7	14	.	.	PROPN
ajlm-2582	7	15	brings	bring	VERB
ajlm-2582	7	16	to	to	PART
ajlm-2582	7	17	light	light	VERB
ajlm-2582	7	18	a	a	DET
ajlm-2582	7	19	significant	significant	ADJ
ajlm-2582	7	20	change	change	NOUN
ajlm-2582	7	21	in	in	ADP
ajlm-2582	7	22	the	the	DET
ajlm-2582	7	23	lipid	lipid	NOUN
ajlm-2582	7	24	profile	profile	NOUN
ajlm-2582	7	25	of	of	ADP
ajlm-2582	7	26	hiv	hiv	PROPN
ajlm-2582	7	27	-	-	PUNCT
ajlm-2582	7	28	positive	positive	ADJ
ajlm-2582	7	29	patients	patient	NOUN
ajlm-2582	7	30	versus	versus	ADP
ajlm-2582	7	31	healthy	healthy	ADJ
ajlm-2582	7	32	controls	control	NOUN
ajlm-2582	7	33	,	,	PUNCT
ajlm-2582	7	34	emphasising	emphasise	VERB
ajlm-2582	7	35	the	the	DET
ajlm-2582	7	36	importance	importance	NOUN
ajlm-2582	7	37	of	of	ADP
ajlm-2582	7	38	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2582	7	39	in	in	ADP
ajlm-2582	7	40	the	the	DET
ajlm-2582	7	41	development	development	NOUN
ajlm-2582	7	42	of	of	ADP
ajlm-2582	7	43	cardiovascular	cardiovascular	ADJ
ajlm-2582	7	44	diseases	disease	NOUN
ajlm-2582	7	45	(	(	PUNCT
ajlm-2582	7	46	cvds).1	cvds).1	NOUN
ajlm-2582	7	47	these	these	DET
ajlm-2582	7	48	results	result	NOUN
ajlm-2582	7	49	are	be	AUX
ajlm-2582	7	50	important	important	ADJ
ajlm-2582	7	51	,	,	PUNCT
ajlm-2582	7	52	because	because	SCONJ
ajlm-2582	7	53	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2582	7	54	is	be	AUX
ajlm-2582	7	55	not	not	PART
ajlm-2582	7	56	only	only	ADV
ajlm-2582	7	57	a	a	DET
ajlm-2582	7	58	common	common	ADJ
ajlm-2582	7	59	metabolic	metabolic	NOUN
ajlm-2582	7	60	complication	complication	NOUN
ajlm-2582	7	61	for	for	ADP
ajlm-2582	7	62	hiv	hiv	PROPN
ajlm-2582	7	63	-	-	PUNCT
ajlm-2582	7	64	positive	positive	ADJ
ajlm-2582	7	65	individuals	individual	NOUN
ajlm-2582	7	66	,	,	PUNCT
ajlm-2582	7	67	but	but	CCONJ
ajlm-2582	7	68	it	it	PRON
ajlm-2582	7	69	also	also	ADV
ajlm-2582	7	70	increases	increase	VERB
ajlm-2582	7	71	risk	risk	NOUN
ajlm-2582	7	72	for	for	ADP
ajlm-2582	7	73	cvds.2	cvds.2	PROPN
ajlm-2582	7	74	therefore	therefore	ADV
ajlm-2582	7	75	,	,	PUNCT
ajlm-2582	7	76	understanding	understand	VERB
ajlm-2582	7	77	the	the	DET
ajlm-2582	7	78	causes	cause	NOUN
ajlm-2582	7	79	of	of	ADP
ajlm-2582	7	80	abnormal	abnormal	ADJ
ajlm-2582	7	81	lipid	lipid	NOUN
ajlm-2582	7	82	metabolism	metabolism	NOUN
ajlm-2582	7	83	is	be	AUX
ajlm-2582	7	84	a	a	DET
ajlm-2582	7	85	critical	critical	ADJ
ajlm-2582	7	86	step	step	NOUN
ajlm-2582	7	87	toward	toward	ADP
ajlm-2582	7	88	disease	disease	NOUN
ajlm-2582	7	89	management	management	NOUN
ajlm-2582	7	90	.	.	PUNCT
ajlm-2582	8	1	unfortunately	unfortunately	ADV
ajlm-2582	8	2	,	,	PUNCT
ajlm-2582	8	3	there	there	PRON
ajlm-2582	8	4	is	be	VERB
ajlm-2582	8	5	no	no	DET
ajlm-2582	8	6	definite	definite	ADJ
ajlm-2582	8	7	explanation	explanation	NOUN
ajlm-2582	8	8	for	for	ADP
ajlm-2582	8	9	why	why	SCONJ
ajlm-2582	8	10	this	this	PRON
ajlm-2582	8	11	happens	happen	VERB
ajlm-2582	8	12	.	.	PUNCT
ajlm-2582	9	1	comorbidities	comorbiditie	NOUN
ajlm-2582	9	2	like	like	ADP
ajlm-2582	9	3	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2582	9	4	and	and	CCONJ
ajlm-2582	9	5	cvds	cvds	PROPN
ajlm-2582	9	6	among	among	ADP
ajlm-2582	9	7	hiv	hiv	PROPN
ajlm-2582	9	8	patients	patient	NOUN
ajlm-2582	9	9	are	be	AUX
ajlm-2582	9	10	multifactorial	multifactorial	ADJ
ajlm-2582	9	11	and	and	CCONJ
ajlm-2582	9	12	have	have	VERB
ajlm-2582	9	13	no	no	DET
ajlm-2582	9	14	single	single	ADJ
ajlm-2582	9	15	cause	cause	NOUN
ajlm-2582	9	16	,	,	PUNCT
ajlm-2582	9	17	but	but	CCONJ
ajlm-2582	9	18	insights	insight	NOUN
ajlm-2582	9	19	indicate	indicate	VERB
ajlm-2582	9	20	that	that	SCONJ
ajlm-2582	9	21	immune	immune	ADJ
ajlm-2582	9	22	dysregulation	dysregulation	NOUN
ajlm-2582	9	23	plays	play	VERB
ajlm-2582	9	24	a	a	DET
ajlm-2582	9	25	central	central	ADJ
ajlm-2582	9	26	role	role	NOUN
ajlm-2582	9	27	in	in	ADP
ajlm-2582	9	28	executing	execute	VERB
ajlm-2582	9	29	pathological	pathological	ADJ
ajlm-2582	9	30	conditions.3	conditions.3	NOUN
ajlm-2582	9	31	in	in	ADP
ajlm-2582	9	32	essence	essence	NOUN
ajlm-2582	9	33	,	,	PUNCT
ajlm-2582	9	34	there	there	PRON
ajlm-2582	9	35	seems	seem	VERB
ajlm-2582	9	36	to	to	PART
ajlm-2582	9	37	be	be	AUX
ajlm-2582	9	38	a	a	DET
ajlm-2582	9	39	connection	connection	NOUN
ajlm-2582	9	40	between	between	ADP
ajlm-2582	9	41	dyslipidaemia	dyslipidaemia	PROPN
ajlm-2582	9	42	,	,	PUNCT
ajlm-2582	9	43	cvds	cvds	PROPN
ajlm-2582	9	44	,	,	PUNCT
ajlm-2582	9	45	hiv	hiv	PROPN
ajlm-2582	9	46	,	,	PUNCT
ajlm-2582	9	47	and	and	CCONJ
ajlm-2582	9	48	immune	immune	NOUN
ajlm-2582	9	49	-	-	PUNCT
ajlm-2582	9	50	related	relate	VERB
ajlm-2582	9	51	pathological	pathological	ADJ
ajlm-2582	9	52	processes	process	NOUN
ajlm-2582	9	53	.	.	PUNCT
ajlm-2582	10	1	among	among	ADP
ajlm-2582	10	2	the	the	DET
ajlm-2582	10	3	possible	possible	ADJ
ajlm-2582	10	4	mechanisms	mechanism	NOUN
ajlm-2582	10	5	,	,	PUNCT
ajlm-2582	10	6	the	the	DET
ajlm-2582	10	7	progressive	progressive	ADJ
ajlm-2582	10	8	loss	loss	NOUN
ajlm-2582	10	9	of	of	ADP
ajlm-2582	10	10	the	the	DET
ajlm-2582	10	11	cd4	cd4	PROPN
ajlm-2582	10	12	+	+	PROPN
ajlm-2582	10	13	t	t	PROPN
ajlm-2582	10	14	-	-	PUNCT
ajlm-2582	10	15	cell	cell	NOUN
ajlm-2582	10	16	population	population	NOUN
ajlm-2582	10	17	is	be	AUX
ajlm-2582	10	18	one	one	NUM
ajlm-2582	10	19	of	of	ADP
ajlm-2582	10	20	the	the	DET
ajlm-2582	10	21	most	most	ADJ
ajlm-2582	10	22	important.4	important.4	ADJ
ajlm-2582	10	23	evidence	evidence	NOUN
ajlm-2582	10	24	indicates	indicate	VERB
ajlm-2582	10	25	that	that	SCONJ
ajlm-2582	10	26	hiv	hiv	PROPN
ajlm-2582	10	27	-	-	PUNCT
ajlm-2582	10	28	positive	positive	ADJ
ajlm-2582	10	29	individuals	individual	NOUN
ajlm-2582	10	30	with	with	ADP
ajlm-2582	10	31	low	low	ADJ
ajlm-2582	10	32	cd4	cd4	PROPN
ajlm-2582	10	33	count	count	NOUN
ajlm-2582	10	34	have	have	VERB
ajlm-2582	10	35	endothelial	endothelial	ADJ
ajlm-2582	10	36	dysfunction	dysfunction	NOUN
ajlm-2582	10	37	and	and	CCONJ
ajlm-2582	10	38	hypertension	hypertension	NOUN
ajlm-2582	10	39	that	that	PRON
ajlm-2582	10	40	is	be	AUX
ajlm-2582	10	41	accompanied	accompany	VERB
ajlm-2582	10	42	by	by	ADP
ajlm-2582	10	43	increased	increase	VERB
ajlm-2582	10	44	cvd	cvd	PROPN
ajlm-2582	10	45	risk.4	risk.4	PROPN
ajlm-2582	10	46	these	these	DET
ajlm-2582	10	47	clinical	clinical	ADJ
ajlm-2582	10	48	conditions	condition	NOUN
ajlm-2582	10	49	are	be	AUX
ajlm-2582	10	50	strongly	strongly	ADV
ajlm-2582	10	51	influenced	influence	VERB
ajlm-2582	10	52	by	by	ADP
ajlm-2582	10	53	both	both	DET
ajlm-2582	10	54	elements	element	NOUN
ajlm-2582	10	55	of	of	ADP
ajlm-2582	10	56	the	the	DET
ajlm-2582	10	57	immune	immune	ADJ
ajlm-2582	10	58	system	system	NOUN
ajlm-2582	10	59	and	and	CCONJ
ajlm-2582	10	60	a	a	DET
ajlm-2582	10	61	broad	broad	ADJ
ajlm-2582	10	62	group	group	NOUN
ajlm-2582	10	63	of	of	ADP
ajlm-2582	10	64	lipid	lipid	NOUN
ajlm-2582	10	65	components.4	components.4	PROPN
ajlm-2582	10	66	hiv	hiv	PROPN
ajlm-2582	10	67	-	-	PUNCT
ajlm-2582	10	68	positive	positive	ADJ
ajlm-2582	10	69	individuals	individual	NOUN
ajlm-2582	10	70	also	also	ADV
ajlm-2582	10	71	have	have	VERB
ajlm-2582	10	72	elevated	elevate	VERB
ajlm-2582	10	73	proportions	proportion	NOUN
ajlm-2582	10	74	of	of	ADP
ajlm-2582	10	75	t	t	PROPN
ajlm-2582	10	76	-	-	PUNCT
ajlm-2582	10	77	helper	helper	NOUN
ajlm-2582	10	78	17	17	NUM
ajlm-2582	10	79	cells	cell	NOUN
ajlm-2582	10	80	,	,	PUNCT
ajlm-2582	10	81	which	which	PRON
ajlm-2582	10	82	may	may	AUX
ajlm-2582	10	83	promote	promote	VERB
ajlm-2582	10	84	inflammation	inflammation	NOUN
ajlm-2582	10	85	,	,	PUNCT
ajlm-2582	10	86	and	and	CCONJ
ajlm-2582	10	87	senescent	senescent	ADJ
ajlm-2582	10	88	cells	cell	NOUN
ajlm-2582	10	89	,	,	PUNCT
ajlm-2582	10	90	which	which	PRON
ajlm-2582	10	91	may	may	AUX
ajlm-2582	10	92	increase	increase	VERB
ajlm-2582	10	93	risk	risk	NOUN
ajlm-2582	10	94	of	of	ADP
ajlm-2582	10	95	cardiovascular	cardiovascular	ADJ
ajlm-2582	10	96	disease	disease	NOUN
ajlm-2582	10	97	,	,	PUNCT
ajlm-2582	10	98	in	in	ADP
ajlm-2582	10	99	hyperlipidemic	hyperlipidemic	ADJ
ajlm-2582	10	100	conditions.4	conditions.4	PROPN
ajlm-2582	10	101	interleukin-2	interleukin-2	NOUN
ajlm-2582	10	102	production	production	NOUN
ajlm-2582	10	103	has	have	AUX
ajlm-2582	10	104	also	also	ADV
ajlm-2582	10	105	been	be	AUX
ajlm-2582	10	106	shown	show	VERB
ajlm-2582	10	107	to	to	PART
ajlm-2582	10	108	increase	increase	VERB
ajlm-2582	10	109	in	in	ADP
ajlm-2582	10	110	these	these	DET
ajlm-2582	10	111	patients	patient	NOUN
ajlm-2582	10	112	and	and	CCONJ
ajlm-2582	10	113	can	can	AUX
ajlm-2582	10	114	affect	affect	VERB
ajlm-2582	10	115	lipid	lipid	ADJ
ajlm-2582	10	116	metabolism	metabolism	NOUN
ajlm-2582	10	117	and	and	CCONJ
ajlm-2582	10	118	cvd	cvd	PROPN
ajlm-2582	10	119	risk.4	risk.4	PROPN
ajlm-2582	10	120	cells	cell	NOUN
ajlm-2582	10	121	of	of	ADP
ajlm-2582	10	122	the	the	DET
ajlm-2582	10	123	monocyte	monocyte	ADJ
ajlm-2582	10	124	-	-	PUNCT
ajlm-2582	10	125	macrophage	macrophage	ADJ
ajlm-2582	10	126	lineage	lineage	NOUN
ajlm-2582	10	127	appear	appear	VERB
ajlm-2582	10	128	to	to	PART
ajlm-2582	10	129	also	also	ADV
ajlm-2582	10	130	play	play	VERB
ajlm-2582	10	131	a	a	DET
ajlm-2582	10	132	role	role	NOUN
ajlm-2582	10	133	in	in	ADP
ajlm-2582	10	134	the	the	DET
ajlm-2582	10	135	complicated	complicated	ADJ
ajlm-2582	10	136	connection	connection	NOUN
ajlm-2582	10	137	between	between	ADP
ajlm-2582	10	138	the	the	DET
ajlm-2582	10	139	immune	immune	ADJ
ajlm-2582	10	140	system	system	NOUN
ajlm-2582	10	141	and	and	CCONJ
ajlm-2582	10	142	hiv	hiv	PROPN
ajlm-2582	10	143	disease	disease	NOUN
ajlm-2582	10	144	,	,	PUNCT
ajlm-2582	10	145	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2582	10	146	,	,	PUNCT
ajlm-2582	10	147	and	and	CCONJ
ajlm-2582	10	148	cvds.5	cvds.5	NOUN
ajlm-2582	10	149	this	this	PRON
ajlm-2582	10	150	is	be	AUX
ajlm-2582	10	151	supported	support	VERB
ajlm-2582	10	152	by	by	ADP
ajlm-2582	10	153	elevation	elevation	NOUN
ajlm-2582	10	154	of	of	ADP
ajlm-2582	10	155	intermediate	intermediate	ADJ
ajlm-2582	10	156	/	/	SYM
ajlm-2582	10	157	inflammatory	inflammatory	ADJ
ajlm-2582	10	158	monocytes	monocyte	VERB
ajlm-2582	10	159	with	with	ADP
ajlm-2582	10	160	proatherogenic	proatherogenic	ADJ
ajlm-2582	10	161	properties	property	NOUN
ajlm-2582	10	162	in	in	ADP
ajlm-2582	10	163	hiv	hiv	PROPN
ajlm-2582	10	164	-	-	PUNCT
ajlm-2582	10	165	positive	positive	ADJ
ajlm-2582	10	166	patients.5	patients.5	NOUN
ajlm-2582	10	167	these	these	DET
ajlm-2582	10	168	cells	cell	NOUN
ajlm-2582	10	169	play	play	VERB
ajlm-2582	10	170	a	a	DET
ajlm-2582	10	171	detrimental	detrimental	ADJ
ajlm-2582	10	172	role	role	NOUN
ajlm-2582	10	173	in	in	ADP
ajlm-2582	10	174	cvd	cvd	PROPN
ajlm-2582	10	175	progression	progression	NOUN
ajlm-2582	10	176	and	and	CCONJ
ajlm-2582	10	177	can	can	AUX
ajlm-2582	10	178	express	express	VERB
ajlm-2582	10	179	abundant	abundant	ADJ
ajlm-2582	10	180	tissue	tissue	NOUN
ajlm-2582	10	181	factor	factor	NOUN
ajlm-2582	10	182	,	,	PUNCT
ajlm-2582	10	183	a	a	DET
ajlm-2582	10	184	risk	risk	NOUN
ajlm-2582	10	185	marker	marker	NOUN
ajlm-2582	10	186	for	for	ADP
ajlm-2582	10	187	cvds.5	cvds.5	PROPN
ajlm-2582	10	188	lipidic	lipidic	PROPN
ajlm-2582	10	189	environment	environment	NOUN
ajlm-2582	10	190	modification	modification	NOUN
ajlm-2582	10	191	is	be	AUX
ajlm-2582	10	192	another	another	DET
ajlm-2582	10	193	reason	reason	NOUN
ajlm-2582	10	194	for	for	ADP
ajlm-2582	10	195	production	production	NOUN
ajlm-2582	10	196	of	of	ADP
ajlm-2582	10	197	tissue	tissue	NOUN
ajlm-2582	10	198	factor	factor	NOUN
ajlm-2582	10	199	in	in	ADP
ajlm-2582	10	200	plaque	plaque	NOUN
ajlm-2582	10	201	macrophages	macrophage	NOUN
ajlm-2582	10	202	;	;	PUNCT
ajlm-2582	10	203	thus	thus	ADV
ajlm-2582	10	204	,	,	PUNCT
ajlm-2582	10	205	interplay	interplay	NOUN
ajlm-2582	10	206	of	of	ADP
ajlm-2582	10	207	lipids	lipid	NOUN
ajlm-2582	10	208	and	and	CCONJ
ajlm-2582	10	209	immune	immune	ADJ
ajlm-2582	10	210	cells	cell	NOUN
ajlm-2582	10	211	might	might	AUX
ajlm-2582	10	212	in	in	ADP
ajlm-2582	10	213	part	part	NOUN
ajlm-2582	10	214	be	be	AUX
ajlm-2582	10	215	responsible	responsible	ADJ
ajlm-2582	10	216	for	for	ADP
ajlm-2582	10	217	the	the	DET
ajlm-2582	10	218	cvd	cvd	PROPN
ajlm-2582	10	219	progression	progression	NOUN
ajlm-2582	10	220	in	in	ADP
ajlm-2582	10	221	infected	infected	ADJ
ajlm-2582	10	222	patients.5	patients.5	PROPN
ajlm-2582	10	223	elevation	elevation	NOUN
ajlm-2582	10	224	of	of	ADP
ajlm-2582	10	225	macrophage	macrophage	ADJ
ajlm-2582	10	226	activation	activation	NOUN
ajlm-2582	10	227	markers	marker	NOUN
ajlm-2582	10	228	,	,	PUNCT
ajlm-2582	10	229	soluble	soluble	ADJ
ajlm-2582	10	230	cd14	cd14	PROPN
ajlm-2582	10	231	,	,	PUNCT
ajlm-2582	10	232	in	in	SCONJ
ajlm-2582	10	233	hiv	hiv	PROPN
ajlm-2582	10	234	-	-	PUNCT
ajlm-2582	10	235	positive	positive	ADJ
ajlm-2582	10	236	patients	patient	NOUN
ajlm-2582	10	237	provides	provide	VERB
ajlm-2582	10	238	additional	additional	ADJ
ajlm-2582	10	239	evidence	evidence	NOUN
ajlm-2582	10	240	for	for	ADP
ajlm-2582	10	241	the	the	DET
ajlm-2582	10	242	importance	importance	NOUN
ajlm-2582	10	243	of	of	ADP
ajlm-2582	10	244	the	the	DET
ajlm-2582	10	245	monocyte	monocyte	ADJ
ajlm-2582	10	246	-	-	PUNCT
ajlm-2582	10	247	macrophage	macrophage	ADJ
ajlm-2582	10	248	lineage	lineage	NOUN
ajlm-2582	10	249	,	,	PUNCT
ajlm-2582	10	250	because	because	SCONJ
ajlm-2582	10	251	they	they	PRON
ajlm-2582	10	252	can	can	AUX
ajlm-2582	10	253	be	be	AUX
ajlm-2582	10	254	associated	associate	VERB
ajlm-2582	10	255	with	with	ADP
ajlm-2582	10	256	clinical	clinical	ADJ
ajlm-2582	10	257	cvd	cvd	PROPN
ajlm-2582	10	258	events	event	NOUN
ajlm-2582	10	259	and	and	CCONJ
ajlm-2582	10	260	dyslipidaemia.6	dyslipidaemia.6	ADJ
ajlm-2582	10	261	monocyte	monocyte	NOUN
ajlm-2582	10	262	and	and	CCONJ
ajlm-2582	10	263	macrophage	macrophage	ADJ
ajlm-2582	10	264	dysfunction	dysfunction	NOUN
ajlm-2582	10	265	in	in	ADP
ajlm-2582	10	266	cholesterol	cholesterol	NOUN
ajlm-2582	10	267	handling	handling	NOUN
ajlm-2582	10	268	as	as	ADP
ajlm-2582	10	269	a	a	DET
ajlm-2582	10	270	cause	cause	NOUN
ajlm-2582	10	271	of	of	ADP
ajlm-2582	10	272	hiv	hiv	PROPN
ajlm-2582	10	273	infection	infection	NOUN
ajlm-2582	10	274	may	may	AUX
ajlm-2582	10	275	also	also	ADV
ajlm-2582	10	276	affect	affect	VERB
ajlm-2582	10	277	the	the	DET
ajlm-2582	10	278	cvd	cvd	PROPN
ajlm-2582	10	279	risk.5	risk.5	NOUN
ajlm-2582	10	280	this	this	PRON
ajlm-2582	10	281	may	may	AUX
ajlm-2582	10	282	occur	occur	VERB
ajlm-2582	10	283	by	by	ADP
ajlm-2582	10	284	down	down	ADP
ajlm-2582	10	285	-	-	PUNCT
ajlm-2582	10	286	regulation	regulation	NOUN
ajlm-2582	10	287	of	of	ADP
ajlm-2582	10	288	adenosine	adenosine	ADJ
ajlm-2582	10	289	triphosphate	triphosphate	NOUN
ajlm-2582	10	290	-	-	PUNCT
ajlm-2582	10	291	binding	bind	VERB
ajlm-2582	10	292	cassette	cassette	NOUN
ajlm-2582	10	293	transporter	transporter	NOUN
ajlm-2582	10	294	a1	a1	NOUN
ajlm-2582	10	295	,	,	PUNCT
ajlm-2582	10	296	which	which	PRON
ajlm-2582	10	297	is	be	AUX
ajlm-2582	10	298	essential	essential	ADJ
ajlm-2582	10	299	for	for	ADP
ajlm-2582	10	300	cholesterol	cholesterol	NOUN
ajlm-2582	10	301	homeostasis	homeostasis	NOUN
ajlm-2582	10	302	and	and	CCONJ
ajlm-2582	10	303	high	high	ADJ
ajlm-2582	10	304	-	-	PUNCT
ajlm-2582	10	305	density	density	NOUN
ajlm-2582	10	306	lipoprotein	lipoprotein	ADJ
ajlm-2582	10	307	metabolism.5	metabolism.5	PROPN
ajlm-2582	10	308	dysregulated	dysregulated	ADJ
ajlm-2582	10	309	inflammation	inflammation	NOUN
ajlm-2582	10	310	is	be	AUX
ajlm-2582	10	311	another	another	DET
ajlm-2582	10	312	risk	risk	NOUN
ajlm-2582	10	313	factor	factor	NOUN
ajlm-2582	10	314	for	for	ADP
ajlm-2582	10	315	both	both	DET
ajlm-2582	10	316	cvd	cvd	PROPN
ajlm-2582	10	317	and	and	CCONJ
ajlm-2582	10	318	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2582	10	319	in	in	ADP
ajlm-2582	10	320	hiv	hiv	PROPN
ajlm-2582	10	321	-	-	PUNCT
ajlm-2582	10	322	positive	positive	ADJ
ajlm-2582	10	323	patients.7	patients.7	NOUN
ajlm-2582	10	324	this	this	PRON
ajlm-2582	10	325	is	be	AUX
ajlm-2582	10	326	supported	support	VERB
ajlm-2582	10	327	by	by	ADP
ajlm-2582	10	328	evidence	evidence	NOUN
ajlm-2582	10	329	,	,	PUNCT
ajlm-2582	10	330	including	include	VERB
ajlm-2582	10	331	(	(	PUNCT
ajlm-2582	10	332	1	1	X
ajlm-2582	10	333	)	)	PUNCT
ajlm-2582	10	334	the	the	DET
ajlm-2582	10	335	increased	increase	VERB
ajlm-2582	10	336	level	level	NOUN
ajlm-2582	10	337	of	of	ADP
ajlm-2582	10	338	high	high	ADJ
ajlm-2582	10	339	-	-	PUNCT
ajlm-2582	10	340	sensitivity	sensitivity	NOUN
ajlm-2582	10	341	c	c	NOUN
ajlm-2582	10	342	-	-	PUNCT
ajlm-2582	10	343	reactive	reactive	ADJ
ajlm-2582	10	344	protein	protein	NOUN
ajlm-2582	10	345	as	as	ADP
ajlm-2582	10	346	a	a	DET
ajlm-2582	10	347	nonspecific	nonspecific	ADJ
ajlm-2582	10	348	inflammatory	inflammatory	ADJ
ajlm-2582	10	349	marker	marker	NOUN
ajlm-2582	10	350	that	that	PRON
ajlm-2582	10	351	increases	increase	VERB
ajlm-2582	10	352	the	the	DET
ajlm-2582	10	353	cvd	cvd	PROPN
ajlm-2582	10	354	risk	risk	NOUN
ajlm-2582	10	355	and	and	CCONJ
ajlm-2582	10	356	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2582	10	357	,	,	PUNCT
ajlm-2582	10	358	(	(	PUNCT
ajlm-2582	10	359	2	2	X
ajlm-2582	10	360	)	)	PUNCT
ajlm-2582	10	361	the	the	DET
ajlm-2582	10	362	increased	increase	VERB
ajlm-2582	10	363	levels	level	NOUN
ajlm-2582	10	364	of	of	ADP
ajlm-2582	10	365	d	d	NOUN
ajlm-2582	10	366	-	-	PUNCT
ajlm-2582	10	367	dimer	dimer	NOUN
ajlm-2582	10	368	that	that	PRON
ajlm-2582	10	369	can	can	AUX
ajlm-2582	10	370	indicate	indicate	VERB
ajlm-2582	10	371	a	a	DET
ajlm-2582	10	372	positive	positive	ADJ
ajlm-2582	10	373	association	association	NOUN
ajlm-2582	10	374	with	with	ADP
ajlm-2582	10	375	lipid	lipid	ADJ
ajlm-2582	10	376	indicators	indicator	NOUN
ajlm-2582	10	377	in	in	ADP
ajlm-2582	10	378	patients	patient	NOUN
ajlm-2582	10	379	with	with	ADP
ajlm-2582	10	380	coronary	coronary	ADJ
ajlm-2582	10	381	artery	artery	NOUN
ajlm-2582	10	382	disease	disease	NOUN
ajlm-2582	10	383	,	,	PUNCT
ajlm-2582	10	384	and	and	CCONJ
ajlm-2582	10	385	(	(	PUNCT
ajlm-2582	10	386	3	3	X
ajlm-2582	10	387	)	)	PUNCT
ajlm-2582	10	388	the	the	DET
ajlm-2582	10	389	increased	increase	VERB
ajlm-2582	10	390	production	production	NOUN
ajlm-2582	10	391	of	of	ADP
ajlm-2582	10	392	interleukin-6	interleukin-6	NUM
ajlm-2582	10	393	that	that	PRON
ajlm-2582	10	394	occurs	occur	VERB
ajlm-2582	10	395	during	during	ADP
ajlm-2582	10	396	hiv	hiv	PROPN
ajlm-2582	10	397	replication	replication	NOUN
ajlm-2582	10	398	and	and	CCONJ
ajlm-2582	10	399	is	be	AUX
ajlm-2582	10	400	associated	associate	VERB
ajlm-2582	10	401	with	with	ADP
ajlm-2582	10	402	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2582	10	403	and	and	CCONJ
ajlm-2582	10	404	increased	increase	VERB
ajlm-2582	10	405	cvd	cvd	PROPN
ajlm-2582	10	406	risk.7	risk.7	VERB
ajlm-2582	10	407	loss	loss	NOUN
ajlm-2582	10	408	of	of	ADP
ajlm-2582	10	409	gut	gut	NOUN
ajlm-2582	10	410	barrier	barrier	NOUN
ajlm-2582	10	411	function	function	NOUN
ajlm-2582	10	412	and	and	CCONJ
ajlm-2582	10	413	the	the	DET
ajlm-2582	10	414	ensuing	ensue	VERB
ajlm-2582	10	415	microbial	microbial	ADJ
ajlm-2582	10	416	translocation	translocation	NOUN
ajlm-2582	10	417	that	that	PRON
ajlm-2582	10	418	is	be	AUX
ajlm-2582	10	419	usually	usually	ADV
ajlm-2582	10	420	associated	associate	VERB
ajlm-2582	10	421	with	with	ADP
ajlm-2582	10	422	hiv	hiv	PROPN
ajlm-2582	10	423	disease	disease	NOUN
ajlm-2582	10	424	progression	progression	NOUN
ajlm-2582	10	425	can	can	AUX
ajlm-2582	10	426	also	also	ADV
ajlm-2582	10	427	elicit	elicit	VERB
ajlm-2582	10	428	an	an	DET
ajlm-2582	10	429	inflammatory	inflammatory	ADJ
ajlm-2582	10	430	cascade.8	cascade.8	VERB
ajlm-2582	10	431	this	this	DET
ajlm-2582	10	432	inflammatory	inflammatory	ADJ
ajlm-2582	10	433	response	response	NOUN
ajlm-2582	10	434	may	may	AUX
ajlm-2582	10	435	induce	induce	VERB
ajlm-2582	10	436	cvd	cvd	PROPN
ajlm-2582	10	437	through	through	ADP
ajlm-2582	10	438	alteration	alteration	NOUN
ajlm-2582	10	439	in	in	ADP
ajlm-2582	10	440	the	the	DET
ajlm-2582	10	441	balance	balance	NOUN
ajlm-2582	10	442	of	of	ADP
ajlm-2582	10	443	t	t	PROPN
ajlm-2582	10	444	-	-	PUNCT
ajlm-2582	10	445	helper	helper	NOUN
ajlm-2582	10	446	17	17	NUM
ajlm-2582	10	447	/	/	SYM
ajlm-2582	10	448	regulatory	regulatory	ADJ
ajlm-2582	10	449	t	t	PROPN
ajlm-2582	10	450	-	-	PUNCT
ajlm-2582	10	451	cells	cell	NOUN
ajlm-2582	10	452	and	and	CCONJ
ajlm-2582	10	453	their	their	PRON
ajlm-2582	10	454	associated	associate	VERB
ajlm-2582	10	455	cytokines.9	cytokines.9	PROPN
ajlm-2582	10	456	t	t	PROPN
ajlm-2582	10	457	-	-	PUNCT
ajlm-2582	10	458	helper	helper	NOUN
ajlm-2582	10	459	17	17	NUM
ajlm-2582	10	460	/	/	SYM
ajlm-2582	10	461	regulatory	regulatory	ADJ
ajlm-2582	10	462	t	t	PROPN
ajlm-2582	10	463	-	-	PUNCT
ajlm-2582	10	464	cells	cell	NOUN
ajlm-2582	10	465	appear	appear	VERB
ajlm-2582	10	466	to	to	PART
ajlm-2582	10	467	be	be	AUX
ajlm-2582	10	468	a	a	DET
ajlm-2582	10	469	bridge	bridge	NOUN
ajlm-2582	10	470	linking	link	VERB
ajlm-2582	10	471	the	the	DET
ajlm-2582	10	472	gut	gut	ADJ
ajlm-2582	10	473	microbiota	microbiota	NOUN
ajlm-2582	10	474	to	to	ADP
ajlm-2582	10	475	host	host	VERB
ajlm-2582	10	476	metabolic	metabolic	PROPN
ajlm-2582	10	477	disorders.9	disorders.9	PROPN
ajlm-2582	10	478	t	t	PROPN
ajlm-2582	10	479	-	-	PUNCT
ajlm-2582	10	480	helper	helper	NOUN
ajlm-2582	10	481	17	17	NUM
ajlm-2582	10	482	and	and	CCONJ
ajlm-2582	10	483	regulatory	regulatory	ADJ
ajlm-2582	10	484	t	t	PROPN
ajlm-2582	10	485	-	-	PUNCT
ajlm-2582	10	486	cells	cell	NOUN
ajlm-2582	10	487	have	have	VERB
ajlm-2582	10	488	antagonistic	antagonistic	ADJ
ajlm-2582	10	489	effects	effect	NOUN
ajlm-2582	10	490	.	.	PUNCT
ajlm-2582	11	1	t	t	PROPN
ajlm-2582	11	2	-	-	PUNCT
ajlm-2582	11	3	helper	helper	NOUN
ajlm-2582	11	4	17	17	NUM
ajlm-2582	11	5	cells	cell	NOUN
ajlm-2582	11	6	secrete	secrete	VERB
ajlm-2582	11	7	pro	pro	ADJ
ajlm-2582	11	8	-	-	ADJ
ajlm-2582	11	9	inflammatory	inflammatory	ADJ
ajlm-2582	11	10	cytokines	cytokine	NOUN
ajlm-2582	11	11	and	and	CCONJ
ajlm-2582	11	12	promote	promote	VERB
ajlm-2582	11	13	intestinal	intestinal	ADJ
ajlm-2582	11	14	inflammation	inflammation	NOUN
ajlm-2582	11	15	,	,	PUNCT
ajlm-2582	11	16	whereas	whereas	SCONJ
ajlm-2582	11	17	regulatory	regulatory	ADJ
ajlm-2582	11	18	t	t	PROPN
ajlm-2582	11	19	-	-	PUNCT
ajlm-2582	11	20	cells	cell	NOUN
ajlm-2582	11	21	are	be	AUX
ajlm-2582	11	22	anti	anti	ADJ
ajlm-2582	11	23	-	-	ADJ
ajlm-2582	11	24	inflammatory.10	inflammatory.10	ADJ
ajlm-2582	11	25	overproduction	overproduction	NOUN
ajlm-2582	11	26	of	of	ADP
ajlm-2582	11	27	pro	pro	ADJ
ajlm-2582	11	28	-	-	ADJ
ajlm-2582	11	29	inflammatory	inflammatory	ADJ
ajlm-2582	11	30	cytokines	cytokine	NOUN
ajlm-2582	11	31	could	could	AUX
ajlm-2582	11	32	contribute	contribute	VERB
ajlm-2582	11	33	to	to	ADP
ajlm-2582	11	34	endothelial	endothelial	ADJ
ajlm-2582	11	35	damage	damage	NOUN
ajlm-2582	11	36	,	,	PUNCT
ajlm-2582	11	37	and	and	CCONJ
ajlm-2582	11	38	cardiovascular	cardiovascular	PROPN
ajlm-2582	11	39	events.5	events.5	PROPN
ajlm-2582	11	40	moreover	moreover	ADV
ajlm-2582	11	41	,	,	PUNCT
ajlm-2582	11	42	lipid	lipid	NOUN
ajlm-2582	11	43	profile	profile	NOUN
ajlm-2582	11	44	abnormality	abnormality	NOUN
ajlm-2582	11	45	due	due	ADP
ajlm-2582	11	46	to	to	ADP
ajlm-2582	11	47	disturbances	disturbance	NOUN
ajlm-2582	11	48	in	in	ADP
ajlm-2582	11	49	inflammatory	inflammatory	ADJ
ajlm-2582	11	50	and	and	CCONJ
ajlm-2582	11	51	immune	immune	ADJ
ajlm-2582	11	52	processes	process	NOUN
ajlm-2582	11	53	may	may	AUX
ajlm-2582	11	54	exacerbate	exacerbate	VERB
ajlm-2582	11	55	the	the	DET
ajlm-2582	11	56	process	process	NOUN
ajlm-2582	11	57	of	of	ADP
ajlm-2582	11	58	cvds	cvds	PROPN
ajlm-2582	11	59	in	in	ADP
ajlm-2582	11	60	infected	infected	ADJ
ajlm-2582	11	61	individuals.5	individuals.5	PROPN
ajlm-2582	11	62	microbial	microbial	ADJ
ajlm-2582	11	63	translocation	translocation	NOUN
ajlm-2582	11	64	is	be	AUX
ajlm-2582	11	65	often	often	ADV
ajlm-2582	11	66	associated	associate	VERB
ajlm-2582	11	67	with	with	ADP
ajlm-2582	11	68	a	a	DET
ajlm-2582	11	69	reduction	reduction	NOUN
ajlm-2582	11	70	in	in	ADP
ajlm-2582	11	71	microbial	microbial	ADJ
ajlm-2582	11	72	diversity	diversity	NOUN
ajlm-2582	11	73	,	,	PUNCT
ajlm-2582	11	74	losing	lose	VERB
ajlm-2582	11	75	the	the	DET
ajlm-2582	11	76	beneficial	beneficial	ADJ
ajlm-2582	11	77	microbes	microbe	NOUN
ajlm-2582	11	78	,	,	PUNCT
ajlm-2582	11	79	and	and	CCONJ
ajlm-2582	11	80	expansion	expansion	NOUN
ajlm-2582	11	81	of	of	ADP
ajlm-2582	11	82	the	the	DET
ajlm-2582	11	83	pathogenic	pathogenic	ADJ
ajlm-2582	11	84	microbes.4	microbes.4	NOUN
ajlm-2582	11	85	these	these	DET
ajlm-2582	11	86	changes	change	NOUN
ajlm-2582	11	87	can	can	AUX
ajlm-2582	11	88	result	result	VERB
ajlm-2582	11	89	in	in	ADP
ajlm-2582	11	90	gut	gut	NOUN
ajlm-2582	11	91	and	and	CCONJ
ajlm-2582	11	92	peripheral	peripheral	ADJ
ajlm-2582	11	93	t	t	PROPN
ajlm-2582	11	94	-	-	PUNCT
ajlm-2582	11	95	cells	cell	NOUN
ajlm-2582	11	96	activation	activation	NOUN
ajlm-2582	11	97	and	and	CCONJ
ajlm-2582	11	98	increases	increase	NOUN
ajlm-2582	11	99	in	in	ADP
ajlm-2582	11	100	plasma	plasma	NOUN
ajlm-2582	11	101	pro	pro	ADJ
ajlm-2582	11	102	-	-	ADJ
ajlm-2582	11	103	inflammatory	inflammatory	ADJ
ajlm-2582	11	104	factors	factor	NOUN
ajlm-2582	11	105	including	include	VERB
ajlm-2582	11	106	tumour	tumour	NOUN
ajlm-2582	11	107	necrosis	necrosis	NOUN
ajlm-2582	11	108	factor	factor	NOUN
ajlm-2582	11	109	-	-	PUNCT
ajlm-2582	11	110	α	α	NOUN
ajlm-2582	11	111	and	and	CCONJ
ajlm-2582	11	112	soluble	soluble	ADJ
ajlm-2582	11	113	cd14.4	cd14.4	NUM
ajlm-2582	11	114	increased	increase	VERB
ajlm-2582	11	115	levels	level	NOUN
ajlm-2582	11	116	of	of	ADP
ajlm-2582	11	117	these	these	DET
ajlm-2582	11	118	molecules	molecule	NOUN
ajlm-2582	11	119	confer	confer	VERB
ajlm-2582	11	120	an	an	DET
ajlm-2582	11	121	increased	increase	VERB
ajlm-2582	11	122	cvd	cvd	PROPN
ajlm-2582	11	123	risk	risk	NOUN
ajlm-2582	11	124	in	in	ADP
ajlm-2582	11	125	chronic	chronic	ADJ
ajlm-2582	11	126	hiv	hiv	PROPN
ajlm-2582	11	127	infection	infection	NOUN
ajlm-2582	11	128	and	and	CCONJ
ajlm-2582	11	129	have	have	VERB
ajlm-2582	11	130	a	a	DET
ajlm-2582	11	131	strong	strong	ADJ
ajlm-2582	11	132	link	link	NOUN
ajlm-2582	11	133	with	with	ADP
ajlm-2582	11	134	dyslipidaemia.4	dyslipidaemia.4	PROPN
ajlm-2582	11	135	overall	overall	ADJ
ajlm-2582	11	136	,	,	PUNCT
ajlm-2582	11	137	the	the	DET
ajlm-2582	11	138	information	information	NOUN
ajlm-2582	11	139	above	above	ADP
ajlm-2582	11	140	covers	cover	VERB
ajlm-2582	11	141	only	only	ADJ
ajlm-2582	11	142	small	small	ADJ
ajlm-2582	11	143	parts	part	NOUN
ajlm-2582	11	144	of	of	ADP
ajlm-2582	11	145	the	the	DET
ajlm-2582	11	146	whole	whole	NOUN
ajlm-2582	11	147	,	,	PUNCT
ajlm-2582	11	148	but	but	CCONJ
ajlm-2582	11	149	provides	provide	VERB
ajlm-2582	11	150	evidence	evidence	NOUN
ajlm-2582	11	151	for	for	ADP
ajlm-2582	11	152	the	the	DET
ajlm-2582	11	153	crucial	crucial	ADJ
ajlm-2582	11	154	role	role	NOUN
ajlm-2582	11	155	of	of	ADP
ajlm-2582	11	156	the	the	DET
ajlm-2582	11	157	immune	immune	ADJ
ajlm-2582	11	158	system	system	NOUN
ajlm-2582	11	159	in	in	ADP
ajlm-2582	11	160	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2582	11	161	and	and	CCONJ
ajlm-2582	11	162	cvd	cvd	PROPN
ajlm-2582	11	163	risk	risk	NOUN
ajlm-2582	11	164	among	among	ADP
ajlm-2582	11	165	hiv	hiv	PROPN
ajlm-2582	11	166	patients	patient	NOUN
ajlm-2582	11	167	.	.	PUNCT
ajlm-2582	12	1	although	although	SCONJ
ajlm-2582	12	2	definite	definite	ADJ
ajlm-2582	12	3	disease	disease	NOUN
ajlm-2582	12	4	mechanisms	mechanism	NOUN
ajlm-2582	12	5	need	need	VERB
ajlm-2582	12	6	to	to	PART
ajlm-2582	12	7	be	be	AUX
ajlm-2582	12	8	established	establish	VERB
ajlm-2582	12	9	,	,	PUNCT
ajlm-2582	12	10	the	the	DET
ajlm-2582	12	11	emergence	emergence	NOUN
ajlm-2582	12	12	of	of	ADP
ajlm-2582	12	13	unifying	unify	VERB
ajlm-2582	12	14	mechanisms	mechanism	NOUN
ajlm-2582	12	15	for	for	ADP
ajlm-2582	12	16	hiv	hiv	PROPN
ajlm-2582	12	17	and	and	CCONJ
ajlm-2582	12	18	related	related	ADJ
ajlm-2582	12	19	disorders	disorder	NOUN
ajlm-2582	12	20	is	be	AUX
ajlm-2582	12	21	not	not	PART
ajlm-2582	12	22	far	far	ADV
ajlm-2582	12	23	-	-	PUNCT
ajlm-2582	12	24	fetched	fetch	VERB
ajlm-2582	12	25	,	,	PUNCT
ajlm-2582	12	26	because	because	SCONJ
ajlm-2582	12	27	the	the	DET
ajlm-2582	12	28	immune	immune	ADJ
ajlm-2582	12	29	system	system	NOUN
ajlm-2582	12	30	is	be	AUX
ajlm-2582	12	31	a	a	DET
ajlm-2582	12	32	system	system	NOUN
ajlm-2582	12	33	of	of	ADP
ajlm-2582	12	34	relations	relation	NOUN
ajlm-2582	12	35	that	that	PRON
ajlm-2582	12	36	interacts	interact	VERB
ajlm-2582	12	37	with	with	ADP
ajlm-2582	12	38	other	other	ADJ
ajlm-2582	12	39	body	body	NOUN
ajlm-2582	12	40	systems	system	NOUN
ajlm-2582	12	41	.	.	PUNCT
ajlm-2582	13	1	lipid	lipid	ADJ
ajlm-2582	13	2	metabolism	metabolism	NOUN
ajlm-2582	13	3	and	and	CCONJ
ajlm-2582	13	4	immune	immune	ADJ
ajlm-2582	13	5	system	system	NOUN
ajlm-2582	13	6	responses	response	NOUN
ajlm-2582	13	7	regulate	regulate	VERB
ajlm-2582	13	8	each	each	DET
ajlm-2582	13	9	other	other	ADJ
ajlm-2582	13	10	,	,	PUNCT
ajlm-2582	13	11	and	and	CCONJ
ajlm-2582	13	12	immune	immune	NOUN
ajlm-2582	13	13	-	-	PUNCT
ajlm-2582	13	14	metabolic	metabolic	NOUN
ajlm-2582	13	15	dysregulation	dysregulation	NOUN
ajlm-2582	13	16	can	can	AUX
ajlm-2582	13	17	contribute	contribute	VERB
ajlm-2582	13	18	to	to	ADP
ajlm-2582	13	19	hiv	hiv	PROPN
ajlm-2582	13	20	-	-	PUNCT
ajlm-2582	13	21	associated	associate	VERB
ajlm-2582	13	22	pathogenesis	pathogenesis	NOUN
ajlm-2582	13	23	and	and	CCONJ
ajlm-2582	13	24	clinical	clinical	ADJ
ajlm-2582	13	25	observations	observation	NOUN
ajlm-2582	13	26	related	relate	VERB
ajlm-2582	13	27	to	to	ADP
ajlm-2582	13	28	hiv.3	hiv.3	PROPN
ajlm-2582	13	29	alternatively	alternatively	ADV
ajlm-2582	13	30	,	,	PUNCT
ajlm-2582	13	31	the	the	DET
ajlm-2582	13	32	heart	heart	NOUN
ajlm-2582	13	33	and	and	CCONJ
ajlm-2582	13	34	the	the	DET
ajlm-2582	13	35	immune	immune	ADJ
ajlm-2582	13	36	system	system	NOUN
ajlm-2582	13	37	are	be	AUX
ajlm-2582	13	38	highly	highly	ADV
ajlm-2582	13	39	integrated	integrate	VERB
ajlm-2582	13	40	systems	system	NOUN
ajlm-2582	13	41	and	and	CCONJ
ajlm-2582	13	42	immune	immune	ADJ
ajlm-2582	13	43	dysregulation	dysregulation	NOUN
ajlm-2582	13	44	plays	play	VERB
ajlm-2582	13	45	an	an	DET
ajlm-2582	13	46	essential	essential	ADJ
ajlm-2582	13	47	role	role	NOUN
ajlm-2582	13	48	in	in	ADP
ajlm-2582	13	49	the	the	DET
ajlm-2582	13	50	development	development	NOUN
ajlm-2582	13	51	of	of	ADP
ajlm-2582	13	52	many	many	ADJ
ajlm-2582	13	53	cvds.3	cvds.3	NOUN
ajlm-2582	13	54	therefore	therefore	ADV
ajlm-2582	13	55	,	,	PUNCT
ajlm-2582	13	56	the	the	DET
ajlm-2582	13	57	harmful	harmful	ADJ
ajlm-2582	13	58	effect	effect	NOUN
ajlm-2582	13	59	of	of	ADP
ajlm-2582	13	60	hiv	hiv	PROPN
ajlm-2582	13	61	infection	infection	NOUN
ajlm-2582	13	62	on	on	ADP
ajlm-2582	13	63	an	an	DET
ajlm-2582	13	64	individual	individual	ADJ
ajlm-2582	13	65	’s	’s	PART
ajlm-2582	13	66	immune	immune	ADJ
ajlm-2582	13	67	system	system	NOUN
ajlm-2582	13	68	can	can	AUX
ajlm-2582	13	69	disrupt	disrupt	VERB
ajlm-2582	13	70	proper	proper	ADJ
ajlm-2582	13	71	functioning	functioning	NOUN
ajlm-2582	13	72	of	of	ADP
ajlm-2582	13	73	different	different	ADJ
ajlm-2582	13	74	body	body	NOUN
ajlm-2582	13	75	systems	system	NOUN
ajlm-2582	13	76	.	.	PUNCT
ajlm-2582	14	1	however	however	ADV
ajlm-2582	14	2	,	,	PUNCT
ajlm-2582	14	3	further	further	ADJ
ajlm-2582	14	4	investigations	investigation	NOUN
ajlm-2582	14	5	are	be	AUX
ajlm-2582	14	6	needed	need	VERB
ajlm-2582	14	7	to	to	PART
ajlm-2582	14	8	elucidate	elucidate	VERB
ajlm-2582	14	9	how	how	SCONJ
ajlm-2582	14	10	the	the	DET
ajlm-2582	14	11	irregularities	irregularity	NOUN
ajlm-2582	14	12	of	of	ADP
ajlm-2582	14	13	the	the	DET
ajlm-2582	14	14	immune	immune	ADJ
ajlm-2582	14	15	system	system	NOUN
ajlm-2582	14	16	contribute	contribute	VERB
ajlm-2582	14	17	to	to	ADP
ajlm-2582	14	18	altered	alter	VERB
ajlm-2582	14	19	lipid	lipid	NOUN
ajlm-2582	14	20	profile	profile	NOUN
ajlm-2582	14	21	and	and	CCONJ
ajlm-2582	14	22	increased	increase	VERB
ajlm-2582	14	23	risk	risk	NOUN
ajlm-2582	14	24	for	for	ADP
ajlm-2582	14	25	cvd	cvd	PROPN
ajlm-2582	14	26	among	among	ADP
ajlm-2582	14	27	hiv	hiv	PROPN
ajlm-2582	14	28	patients	patient	NOUN
ajlm-2582	14	29	.	.	PUNCT
ajlm-2582	15	1	acknowledgements	acknowledgement	NOUN
ajlm-2582	15	2	competing	compete	VERB
ajlm-2582	15	3	interests	interest	NOUN
ajlm-2582	15	4	the	the	DET
ajlm-2582	15	5	author	author	NOUN
ajlm-2582	15	6	declares	declare	VERB
ajlm-2582	15	7	that	that	SCONJ
ajlm-2582	15	8	they	they	PRON
ajlm-2582	15	9	have	have	VERB
ajlm-2582	15	10	no	no	DET
ajlm-2582	15	11	financial	financial	ADJ
ajlm-2582	15	12	or	or	CCONJ
ajlm-2582	15	13	personal	personal	ADJ
ajlm-2582	15	14	relationships	relationship	NOUN
ajlm-2582	15	15	that	that	PRON
ajlm-2582	15	16	may	may	AUX
ajlm-2582	15	17	have	have	AUX
ajlm-2582	15	18	inappropriately	inappropriately	ADV
ajlm-2582	15	19	influenced	influence	VERB
ajlm-2582	15	20	them	they	PRON
ajlm-2582	15	21	in	in	ADP
ajlm-2582	15	22	writing	write	VERB
ajlm-2582	15	23	this	this	DET
ajlm-2582	15	24	scientific	scientific	ADJ
ajlm-2582	15	25	letter	letter	NOUN
ajlm-2582	15	26	.	.	PUNCT
ajlm-2582	16	1	author	author	NOUN
ajlm-2582	16	2	’s	’s	PART
ajlm-2582	16	3	contribution	contribution	NOUN
ajlm-2582	16	4	z.j	z.j	PROPN
ajlm-2582	16	5	.	.	PROPN
ajlm-2582	16	6	is	be	AUX
ajlm-2582	16	7	the	the	DET
ajlm-2582	16	8	sole	sole	ADJ
ajlm-2582	16	9	author	author	NOUN
ajlm-2582	16	10	of	of	ADP
ajlm-2582	16	11	this	this	DET
ajlm-2582	16	12	scientific	scientific	ADJ
ajlm-2582	16	13	letter	letter	NOUN
ajlm-2582	16	14	.	.	PUNCT
ajlm-2582	17	1	sources	source	NOUN
ajlm-2582	17	2	of	of	ADP
ajlm-2582	17	3	support	support	NOUN
ajlm-2582	17	4	this	this	DET
ajlm-2582	17	5	research	research	NOUN
ajlm-2582	17	6	received	receive	VERB
ajlm-2582	17	7	no	no	DET
ajlm-2582	17	8	specific	specific	ADJ
ajlm-2582	17	9	grant	grant	NOUN
ajlm-2582	17	10	from	from	ADP
ajlm-2582	17	11	any	any	DET
ajlm-2582	17	12	funding	funding	NOUN
ajlm-2582	17	13	agency	agency	NOUN
ajlm-2582	17	14	in	in	ADP
ajlm-2582	17	15	the	the	DET
ajlm-2582	17	16	public	public	ADJ
ajlm-2582	17	17	,	,	PUNCT
ajlm-2582	17	18	commercial	commercial	ADJ
ajlm-2582	17	19	,	,	PUNCT
ajlm-2582	17	20	or	or	CCONJ
ajlm-2582	17	21	not	not	PART
ajlm-2582	17	22	-	-	PUNCT
ajlm-2582	17	23	for	for	ADP
ajlm-2582	17	24	-	-	PUNCT
ajlm-2582	17	25	profit	profit	NOUN
ajlm-2582	17	26	sectors	sector	NOUN
ajlm-2582	17	27	.	.	PUNCT
ajlm-2582	18	1	data	datum	NOUN
ajlm-2582	18	2	availability	availability	NOUN
ajlm-2582	18	3	data	datum	NOUN
ajlm-2582	18	4	sharing	sharing	NOUN
ajlm-2582	18	5	is	be	AUX
ajlm-2582	18	6	not	not	PART
ajlm-2582	18	7	applicable	applicable	ADJ
ajlm-2582	18	8	to	to	ADP
ajlm-2582	18	9	this	this	DET
ajlm-2582	18	10	scientific	scientific	ADJ
ajlm-2582	18	11	letter	letter	NOUN
ajlm-2582	18	12	as	as	SCONJ
ajlm-2582	18	13	no	no	DET
ajlm-2582	18	14	new	new	ADJ
ajlm-2582	18	15	data	datum	NOUN
ajlm-2582	18	16	were	be	AUX
ajlm-2582	18	17	created	create	VERB
ajlm-2582	18	18	or	or	CCONJ
ajlm-2582	18	19	analysed	analyse	VERB
ajlm-2582	18	20	.	.	PUNCT
ajlm-2582	19	1	disclaimer	disclaimer	VERB
ajlm-2582	19	2	the	the	DET
ajlm-2582	19	3	views	view	NOUN
ajlm-2582	19	4	and	and	CCONJ
ajlm-2582	19	5	opinions	opinion	NOUN
ajlm-2582	19	6	expressed	express	VERB
ajlm-2582	19	7	in	in	ADP
ajlm-2582	19	8	this	this	DET
ajlm-2582	19	9	scientific	scientific	ADJ
ajlm-2582	19	10	letter	letter	NOUN
ajlm-2582	19	11	are	be	AUX
ajlm-2582	19	12	those	those	PRON
ajlm-2582	19	13	of	of	ADP
ajlm-2582	19	14	the	the	DET
ajlm-2582	19	15	author	author	NOUN
ajlm-2582	19	16	.	.	PUNCT
ajlm-2582	20	1	it	it	PRON
ajlm-2582	20	2	does	do	AUX
ajlm-2582	20	3	not	not	PART
ajlm-2582	20	4	necessarily	necessarily	ADV
ajlm-2582	20	5	reflect	reflect	VERB
ajlm-2582	20	6	the	the	DET
ajlm-2582	20	7	official	official	ADJ
ajlm-2582	20	8	policy	policy	NOUN
ajlm-2582	20	9	or	or	CCONJ
ajlm-2582	20	10	position	position	NOUN
ajlm-2582	20	11	of	of	ADP
ajlm-2582	20	12	any	any	DET
ajlm-2582	20	13	affiliated	affiliated	ADJ
ajlm-2582	20	14	institution	institution	NOUN
ajlm-2582	20	15	,	,	PUNCT
ajlm-2582	20	16	funder	funder	NOUN
ajlm-2582	20	17	,	,	PUNCT
ajlm-2582	20	18	agency	agency	NOUN
ajlm-2582	20	19	,	,	PUNCT
ajlm-2582	20	20	or	or	CCONJ
ajlm-2582	20	21	that	that	PRON
ajlm-2582	20	22	of	of	ADP
ajlm-2582	20	23	the	the	DET
ajlm-2582	20	24	publisher	publisher	NOUN
ajlm-2582	20	25	.	.	PUNCT
ajlm-2582	21	1	the	the	DET
ajlm-2582	21	2	author	author	NOUN
ajlm-2582	21	3	is	be	AUX
ajlm-2582	21	4	responsible	responsible	ADJ
ajlm-2582	21	5	for	for	ADP
ajlm-2582	21	6	this	this	DET
ajlm-2582	21	7	scientific	scientific	ADJ
ajlm-2582	21	8	letter	letter	NOUN
ajlm-2582	21	9	’s	’s	PART
ajlm-2582	21	10	content	content	NOUN
ajlm-2582	21	11	.	.	PUNCT
ajlm-2582	22	1	references	reference	NOUN
ajlm-2582	22	2	okunorobo	okunorobo	PROPN
ajlm-2582	22	3	mn	mn	PROPN
ajlm-2582	22	4	,	,	PUNCT
ajlm-2582	22	5	nnamah	nnamah	PROPN
ajlm-2582	22	6	nk	nk	PROPN
ajlm-2582	22	7	,	,	PUNCT
ajlm-2582	22	8	ude	ude	PROPN
ajlm-2582	22	9	ua	ua	PROPN
ajlm-2582	22	10	,	,	PUNCT
ajlm-2582	22	11	ude	ude	NOUN
ajlm-2582	22	12	ea	ea	NOUN
ajlm-2582	22	13	.	.	PUNCT
ajlm-2582	23	1	lipids	lipid	NOUN
ajlm-2582	23	2	and	and	CCONJ
ajlm-2582	23	3	apolipoproteins	apolipoprotein	VERB
ajlm-2582	23	4	c	c	PROPN
ajlm-2582	23	5	-	-	PUNCT
ajlm-2582	23	6	iii	iii	NOUN
ajlm-2582	23	7	and	and	CCONJ
ajlm-2582	23	8	e	e	X
ajlm-2582	23	9	among	among	ADP
ajlm-2582	23	10	treatment	treatment	NOUN
ajlm-2582	23	11	-	-	PUNCT
ajlm-2582	23	12	naïve	naïve	ADJ
ajlm-2582	23	13	and	and	CCONJ
ajlm-2582	23	14	treatment	treatment	NOUN
ajlm-2582	23	15	-	-	PUNCT
ajlm-2582	23	16	experienced	experience	VERB
ajlm-2582	23	17	persons	person	NOUN
ajlm-2582	23	18	with	with	ADP
ajlm-2582	23	19	hiv	hiv	PROPN
ajlm-2582	23	20	in	in	ADP
ajlm-2582	23	21	nigeria	nigeria	PROPN
ajlm-2582	23	22	.	.	PUNCT
ajlm-2582	24	1	afr	afr	PROPN
ajlm-2582	24	2	j	j	PROPN
ajlm-2582	24	3	lab	lab	PROPN
ajlm-2582	24	4	med	me	VERB
ajlm-2582	24	5	.	.	PUNCT
ajlm-2582	25	1	2023;12(1):2018	2023;12(1):2018	NOUN
ajlm-2582	25	2	.	.	PUNCT
ajlm-2582	26	1	https://doi.org/10.4102/ajlm.v12i1.2018	https://doi.org/10.4102/ajlm.v12i1.2018	NOUN
ajlm-2582	26	2	wańczura	wańczura	PROPN
ajlm-2582	26	3	p	p	NOUN
ajlm-2582	26	4	,	,	PUNCT
ajlm-2582	26	5	aebisher	aebisher	PROPN
ajlm-2582	26	6	d	d	PROPN
ajlm-2582	26	7	,	,	PUNCT
ajlm-2582	26	8	iwański	iwański	PROPN
ajlm-2582	26	9	ma	ma	PROPN
ajlm-2582	26	10	,	,	PUNCT
ajlm-2582	26	11	myśliwiec	myśliwiec	VERB
ajlm-2582	26	12	a	a	PRON
ajlm-2582	26	13	,	,	PUNCT
ajlm-2582	26	14	dynarowicz	dynarowicz	PROPN
ajlm-2582	26	15	k	k	NOUN
ajlm-2582	26	16	,	,	PUNCT
ajlm-2582	26	17	bartusik	bartusik	NOUN
ajlm-2582	26	18	-	-	PUNCT
ajlm-2582	26	19	aebisher	aebisher	NOUN
ajlm-2582	26	20	d.	d.	PROPN
ajlm-2582	26	21	the	the	DET
ajlm-2582	26	22	essence	essence	NOUN
ajlm-2582	26	23	of	of	ADP
ajlm-2582	26	24	lipoproteins	lipoprotein	NOUN
ajlm-2582	26	25	in	in	ADP
ajlm-2582	26	26	cardiovascular	cardiovascular	ADJ
ajlm-2582	26	27	health	health	NOUN
ajlm-2582	26	28	and	and	CCONJ
ajlm-2582	26	29	diseases	disease	NOUN
ajlm-2582	26	30	treated	treat	VERB
ajlm-2582	26	31	by	by	ADP
ajlm-2582	26	32	photodynamic	photodynamic	ADJ
ajlm-2582	26	33	therapy	therapy	NOUN
ajlm-2582	26	34	.	.	PUNCT
ajlm-2582	27	1	biomedicines	biomedicine	NOUN
ajlm-2582	27	2	.	.	PUNCT
ajlm-2582	28	1	2024;12(5):961	2024;12(5):961	NUM
ajlm-2582	28	2	.	.	PUNCT
ajlm-2582	29	1	https://doi.org/10.3390/biomedicines12050961	https://doi.org/10.3390/biomedicines12050961	PROPN
ajlm-2582	29	2	ketelhuth	ketelhuth	PROPN
ajlm-2582	29	3	dfj	dfj	NOUN
ajlm-2582	29	4	,	,	PUNCT
ajlm-2582	29	5	lutgens	lutgen	NOUN
ajlm-2582	29	6	e	e	NOUN
ajlm-2582	29	7	,	,	PUNCT
ajlm-2582	29	8	bäck	bäck	PROPN
ajlm-2582	29	9	m	m	PROPN
ajlm-2582	29	10	,	,	PUNCT
ajlm-2582	29	11	et	et	PROPN
ajlm-2582	29	12	al	al	PROPN
ajlm-2582	29	13	.	.	PROPN
ajlm-2582	29	14	immunometabolism	immunometabolism	PROPN
ajlm-2582	29	15	and	and	CCONJ
ajlm-2582	29	16	atherosclerosis	atherosclerosis	NOUN
ajlm-2582	29	17	:	:	PUNCT
ajlm-2582	29	18	perspectives	perspective	NOUN
ajlm-2582	29	19	and	and	CCONJ
ajlm-2582	29	20	clinical	clinical	ADJ
ajlm-2582	29	21	significance	significance	NOUN
ajlm-2582	29	22	:	:	PUNCT
ajlm-2582	29	23	a	a	DET
ajlm-2582	29	24	position	position	NOUN
ajlm-2582	29	25	paper	paper	NOUN
ajlm-2582	29	26	from	from	ADP
ajlm-2582	29	27	the	the	DET
ajlm-2582	29	28	working	work	VERB
ajlm-2582	29	29	group	group	NOUN
ajlm-2582	29	30	on	on	ADP
ajlm-2582	29	31	atherosclerosis	atherosclerosis	NOUN
ajlm-2582	29	32	and	and	CCONJ
ajlm-2582	29	33	vascular	vascular	ADJ
ajlm-2582	29	34	biology	biology	NOUN
ajlm-2582	29	35	of	of	ADP
ajlm-2582	29	36	the	the	DET
ajlm-2582	29	37	european	european	ADJ
ajlm-2582	29	38	society	society	NOUN
ajlm-2582	29	39	of	of	ADP
ajlm-2582	29	40	cardiology	cardiology	NOUN
ajlm-2582	29	41	.	.	PUNCT
ajlm-2582	30	1	cardiovasc	cardiovasc	PROPN
ajlm-2582	30	2	res	re	NOUN
ajlm-2582	30	3	.	.	PUNCT
ajlm-2582	31	1	2019;115(9):1385–1392	2019;115(9):1385–1392	NUM
ajlm-2582	31	2	.	.	PUNCT
ajlm-2582	32	1	https://doi.org/10.1093/cvr/cvz166	https://doi.org/10.1093/cvr/cvz166	PROPN
ajlm-2582	32	2	lembas	lembas	X
ajlm-2582	32	3	a	a	DET
ajlm-2582	32	4	,	,	PUNCT
ajlm-2582	32	5	załęski	załęski	NOUN
ajlm-2582	32	6	a	a	PRON
ajlm-2582	32	7	,	,	PUNCT
ajlm-2582	32	8	peller	peller	PROPN
ajlm-2582	32	9	m	m	PROPN
ajlm-2582	32	10	,	,	PUNCT
ajlm-2582	32	11	mikuła	mikuła	PROPN
ajlm-2582	32	12	t	t	PROPN
ajlm-2582	32	13	,	,	PUNCT
ajlm-2582	32	14	wiercińska	wiercińska	ADJ
ajlm-2582	32	15	-	-	PUNCT
ajlm-2582	32	16	drapało	drapało	ADJ
ajlm-2582	32	17	a.	a.	NOUN
ajlm-2582	32	18	human	human	ADJ
ajlm-2582	32	19	immunodeficiency	immunodeficiency	NOUN
ajlm-2582	32	20	virus	virus	NOUN
ajlm-2582	32	21	as	as	ADP
ajlm-2582	32	22	a	a	DET
ajlm-2582	32	23	risk	risk	NOUN
ajlm-2582	32	24	factor	factor	NOUN
ajlm-2582	32	25	for	for	ADP
ajlm-2582	32	26	cardiovascular	cardiovascular	ADJ
ajlm-2582	32	27	disease	disease	NOUN
ajlm-2582	32	28	.	.	PUNCT
ajlm-2582	33	1	cardiovasc	cardiovasc	PROPN
ajlm-2582	33	2	toxicol	toxicol	PROPN
ajlm-2582	33	3	.	.	PUNCT
ajlm-2582	34	1	2024;24(1):1–14	2024;24(1):1–14	NUM
ajlm-2582	34	2	.	.	PUNCT
ajlm-2582	34	3	https://doi.org/10.1007/s12012-023-09815-4	https://doi.org/10.1007/s12012-023-09815-4	NUM
ajlm-2582	34	4	nou	nou	PROPN
ajlm-2582	34	5	e	e	PROPN
ajlm-2582	34	6	,	,	PUNCT
ajlm-2582	34	7	lo	lo	PROPN
ajlm-2582	34	8	j	j	PROPN
ajlm-2582	34	9	,	,	PUNCT
ajlm-2582	34	10	grinspoon	grinspoon	PROPN
ajlm-2582	34	11	sk	sk	PROPN
ajlm-2582	34	12	.	.	PROPN
ajlm-2582	34	13	inflammation	inflammation	PROPN
ajlm-2582	34	14	,	,	PUNCT
ajlm-2582	34	15	immune	immune	ADJ
ajlm-2582	34	16	activation	activation	NOUN
ajlm-2582	34	17	,	,	PUNCT
ajlm-2582	34	18	and	and	CCONJ
ajlm-2582	34	19	cardiovascular	cardiovascular	ADJ
ajlm-2582	34	20	disease	disease	NOUN
ajlm-2582	34	21	in	in	ADP
ajlm-2582	34	22	hiv	hiv	PROPN
ajlm-2582	34	23	.	.	PUNCT
ajlm-2582	35	1	aids	aids	PROPN
ajlm-2582	35	2	.	.	PUNCT
ajlm-2582	36	1	2016;30(10):1495–1509	2016;30(10):1495–1509	X
ajlm-2582	36	2	.	.	PUNCT
ajlm-2582	37	1	https://doi.org/10.1097/qad.0000000000001109	https://doi.org/10.1097/qad.0000000000001109	ADJ
ajlm-2582	37	2	obare	obare	NOUN
ajlm-2582	37	3	lm	lm	PROPN
ajlm-2582	37	4	,	,	PUNCT
ajlm-2582	37	5	temu	temu	PROPN
ajlm-2582	37	6	t	t	PROPN
ajlm-2582	37	7	,	,	PUNCT
ajlm-2582	37	8	mallal	mallal	PROPN
ajlm-2582	37	9	sa	sa	PROPN
ajlm-2582	37	10	,	,	PUNCT
ajlm-2582	37	11	wanjalla	wanjalla	PROPN
ajlm-2582	37	12	cn	cn	PROPN
ajlm-2582	37	13	.	.	PROPN
ajlm-2582	37	14	inflammation	inflammation	NOUN
ajlm-2582	37	15	in	in	ADP
ajlm-2582	37	16	hiv	hiv	PROPN
ajlm-2582	37	17	and	and	CCONJ
ajlm-2582	37	18	its	its	PRON
ajlm-2582	37	19	impact	impact	NOUN
ajlm-2582	37	20	on	on	ADP
ajlm-2582	37	21	atherosclerotic	atherosclerotic	ADJ
ajlm-2582	37	22	cardiovascular	cardiovascular	ADJ
ajlm-2582	37	23	disease	disease	NOUN
ajlm-2582	37	24	.	.	PUNCT
ajlm-2582	38	1	circ	circ	PROPN
ajlm-2582	38	2	res	re	NOUN
ajlm-2582	38	3	.	.	PUNCT
ajlm-2582	39	1	2024;134(11):1515–1545	2024;134(11):1515–1545	NUM
ajlm-2582	39	2	.	.	PUNCT
ajlm-2582	40	1	https://doi.org/10.1161/circresaha.124.323891	https://doi.org/10.1161/circresaha.124.323891	ADJ
ajlm-2582	40	2	hmiel	hmiel	NOUN
ajlm-2582	40	3	l	l	PROPN
ajlm-2582	40	4	,	,	PUNCT
ajlm-2582	40	5	zhang	zhang	PROPN
ajlm-2582	40	6	s	s	PROPN
ajlm-2582	40	7	,	,	PUNCT
ajlm-2582	40	8	obare	obare	NOUN
ajlm-2582	40	9	lm	lm	PROPN
ajlm-2582	40	10	,	,	PUNCT
ajlm-2582	40	11	et	et	PROPN
ajlm-2582	40	12	al	al	PROPN
ajlm-2582	40	13	.	.	PROPN
ajlm-2582	40	14	inflammatory	inflammatory	ADJ
ajlm-2582	40	15	and	and	CCONJ
ajlm-2582	40	16	immune	immune	ADJ
ajlm-2582	40	17	mechanisms	mechanism	NOUN
ajlm-2582	40	18	for	for	ADP
ajlm-2582	40	19	atherosclerotic	atherosclerotic	ADJ
ajlm-2582	40	20	cardiovascular	cardiovascular	ADJ
ajlm-2582	40	21	disease	disease	NOUN
ajlm-2582	40	22	in	in	ADP
ajlm-2582	40	23	hiv	hiv	PROPN
ajlm-2582	40	24	.	.	PUNCT
ajlm-2582	41	1	int	int	PROPN
ajlm-2582	41	2	j	j	PROPN
ajlm-2582	41	3	mol	mol	ADP
ajlm-2582	41	4	sci	sci	PROPN
ajlm-2582	41	5	.	.	PUNCT
ajlm-2582	42	1	2024;25(13):7266	2024;25(13):7266	X
ajlm-2582	42	2	.	.	X
ajlm-2582	42	3	https://doi.org/10.3390/ijms25137266	https://doi.org/10.3390/ijms25137266	VERB
ajlm-2582	42	4	trøseid	trøseid	PROPN
ajlm-2582	42	5	m	m	PROPN
ajlm-2582	42	6	,	,	PUNCT
ajlm-2582	42	7	nielsen	nielsen	PROPN
ajlm-2582	42	8	sd	sd	PROPN
ajlm-2582	42	9	,	,	PUNCT
ajlm-2582	42	10	vujkovic	vujkovic	ADJ
ajlm-2582	42	11	-	-	PUNCT
ajlm-2582	42	12	cvijin	cvijin	NOUN
ajlm-2582	42	13	i.	i.	NOUN
ajlm-2582	42	14	gut	gut	NOUN
ajlm-2582	42	15	microbiome	microbiome	ADJ
ajlm-2582	42	16	and	and	CCONJ
ajlm-2582	42	17	cardiometabolic	cardiometabolic	NOUN
ajlm-2582	42	18	comorbidities	comorbiditie	NOUN
ajlm-2582	42	19	in	in	ADP
ajlm-2582	42	20	people	people	NOUN
ajlm-2582	42	21	living	live	VERB
ajlm-2582	42	22	with	with	ADP
ajlm-2582	42	23	hiv	hiv	PROPN
ajlm-2582	42	24	.	.	PUNCT
ajlm-2582	43	1	microbiome	microbiome	NOUN
ajlm-2582	43	2	.	.	PUNCT
ajlm-2582	44	1	2024;12:106	2024;12:106	X
ajlm-2582	44	2	.	.	PUNCT
ajlm-2582	45	1	https://doi.org/10.1186/s40168-024-01815-y	https://doi.org/10.1186/s40168-024-01815-y	PROPN
ajlm-2582	45	2	liu	liu	PROPN
ajlm-2582	45	3	j	j	PROPN
ajlm-2582	45	4	,	,	PUNCT
ajlm-2582	45	5	liu	liu	PROPN
ajlm-2582	45	6	f	f	PROPN
ajlm-2582	45	7	,	,	PUNCT
ajlm-2582	45	8	liang	liang	PROPN
ajlm-2582	45	9	t	t	PROPN
ajlm-2582	45	10	,	,	PUNCT
ajlm-2582	45	11	et	et	PROPN
ajlm-2582	45	12	al	al	PROPN
ajlm-2582	45	13	.	.	PUNCT
ajlm-2582	46	1	the	the	DET
ajlm-2582	46	2	roles	role	NOUN
ajlm-2582	46	3	of	of	ADP
ajlm-2582	46	4	th	th	NOUN
ajlm-2582	46	5	cells	cell	NOUN
ajlm-2582	46	6	in	in	ADP
ajlm-2582	46	7	myocardial	myocardial	ADJ
ajlm-2582	46	8	infarction	infarction	NOUN
ajlm-2582	46	9	.	.	PUNCT
ajlm-2582	47	1	cell	cell	NOUN
ajlm-2582	47	2	death	death	NOUN
ajlm-2582	47	3	discov	discov	NOUN
ajlm-2582	47	4	.	.	PUNCT
ajlm-2582	48	1	2024;10:287	2024;10:287	X
ajlm-2582	48	2	.	.	PUNCT
ajlm-2582	49	1	https://doi.org/10.1038/s41420-024-02064-6	https://doi.org/10.1038/s41420-024-02064-6	NUM
ajlm-2582	49	2	tolomeo	tolomeo	PROPN
ajlm-2582	49	3	m	m	PROPN
ajlm-2582	49	4	,	,	PUNCT
ajlm-2582	49	5	cascio	cascio	PROPN
ajlm-2582	49	6	a.	a.	NOUN
ajlm-2582	49	7	the	the	DET
ajlm-2582	49	8	complex	complex	ADJ
ajlm-2582	49	9	dysregulations	dysregulation	NOUN
ajlm-2582	49	10	of	of	ADP
ajlm-2582	49	11	cd4	cd4	PROPN
ajlm-2582	49	12	t	t	PROPN
ajlm-2582	49	13	cell	cell	NOUN
ajlm-2582	49	14	subtypes	subtype	NOUN
ajlm-2582	49	15	in	in	ADP
ajlm-2582	49	16	hiv	hiv	PROPN
ajlm-2582	49	17	infection	infection	NOUN
ajlm-2582	49	18	.	.	PUNCT
ajlm-2582	50	1	int	int	PROPN
ajlm-2582	50	2	j	j	PROPN
ajlm-2582	50	3	mol	mol	ADP
ajlm-2582	50	4	sci	sci	PROPN
ajlm-2582	50	5	.	.	PUNCT
ajlm-2582	51	1	2024;25(14):7512	2024;25(14):7512	X
ajlm-2582	51	2	.	.	PUNCT
ajlm-2582	52	1	https://doi.org/10.3390/ijms25147512	https://doi.org/10.3390/ijms25147512	PROPN